NCT02156245

Brief Summary

The aim of this study is to assess the efficacy of a rehabilitation protocol based on individualized combined eccentric and concentric cycle ergometer training compared to classical concentric cycle training among patients with either coronary artery disease (CAD) or chronic obstructive pulmonary disease (COPD). This study will therefore evaluate the efficacy of combined eccentric/concentric training on physical capacity and overall autonomy, and will analyse the adaptive mechanisms with regard to both adaptation to cardiac and muscular effort and tolerance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 16, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 5, 2014

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2019

Completed
Last Updated

July 22, 2019

Status Verified

July 1, 2019

Enrollment Period

5.5 years

First QC Date

March 5, 2014

Last Update Submit

July 19, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • For patients with CAD: Distance covered during a 6-minute walk test and triceps surae maximal isometric force

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • For COPD patients : Endurance time at 75 % of peak workload achieved on a cycle ergometer during the initial concentric cardiopulmonary exercise test (CPET)

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

Secondary Outcomes (24)

  • For CAD patients: Functional Independence Measure

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • For CAD patients: Timed up and go test

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • For CAD patients: Step test with gas exchange measurement

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • For CAD patients: Distance covered in the 6-minute walk test

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • For CAD patients: peak VO2 and 1st ventilation adaptation threshold

    Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

  • +19 more secondary outcomes

Study Arms (2)

"Conventional" group

EXPERIMENTAL
Other: conventional rehabilitation program (including concentric cycle ergometer)

"Combined" group

EXPERIMENTAL
Other: cycling included into a conventional rehabilitation program

Interventions

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons who have provided written informed consent
  • Healthy volunteers:
  • Men or women aged between 40 and 75 years.
  • Patients with CAD:
  • Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program.
  • Left ventricular ejection fraction on echocardiography (Simpson methode) \> 45 %
  • Patients with Chronic obstructive pulmonary disease:
  • Men or women aged between 40 and 75 years
  • Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC \< 0.70 and FEV1 ≤ 60% of predicted value)
  • Patient not on oxygen therapy (24h/24)

You may not qualify if:

  • Person without national health insurance cover
  • Severe, obstructive cardiopathy
  • Severe aortic valve stenosis,
  • Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test
  • Cardiac intracavitary thrombus,
  • Severe pulmonary artery hypertension (PAHT systolic \>70mmHg),
  • Recent history of venous thromboembolism (previous 3 months),
  • Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test \< 24),
  • Heart transplant,
  • Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…).
  • Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index \< 0.6) or orthopedic (degenerative or inflammatory rheumatism).
  • Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de BESANCON

Besançon, 25000, France

Location

CHU de DIJON

Dijon, 21079, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2014

First Posted

June 5, 2014

Study Start

September 16, 2013

Primary Completion

April 3, 2019

Study Completion

April 3, 2019

Last Updated

July 22, 2019

Record last verified: 2019-07

Locations